Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) Peptide
CLN8
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN5612934
-
-
Antigène
Tous les produits CLN8
-
CLN8
(Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
-
Source
-
Synthetic
-
Application
-
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
Séquence
-
MNPASDGGTS ESIFDLDYAS WGIRSTLMVA GFVFYLGVFV VCHQLSSSLN
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CLN8 antibody, catalog no. 70R-7114
-
-
-
Indications d'application
-
Optimal working dilution should be determined by the investigator.
-
Restrictions
-
For Research Use only
-
-
Format
-
Lyophilized
-
Buffer
-
Lyophilized powder. Add 100 μL of distilled water for a final peptide concentration is 1 mg/mL.
-
Stock
-
-20 °C
-
Stockage commentaire
-
Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
-
-
Antigène
-
CLN8
(Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
-
Synonymes
-
mnd Peptide, C8orf61 Peptide, EPMR Peptide, CLN8, transmembrane ER and ERGIC protein Peptide, ceroid-lipofuscinosis, neuronal 8 Peptide, CLN8 Peptide, Cln8 Peptide
-
Vous êtes ici:
-
Page d'accueil
-
Peptides
-
CLN8
-
Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) Peptide (ABIN5612934)